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1. Introduction
The importance of peptides and proteins in biology and
medicine has inspired chemists to consider methods that
bring about their synthesis for over a century.
[1] In most
popular modern methods the peptide thioester, whether
produced explicitly or transiently, plays a prominent role
in the assembly of proteins and their analogues using con-
vergent coupling strategies.
[2] Native Chemical Ligation
(NCL)
[2b] has proved particularly useful, since it provides
access to native proteins by coupling peptide thioesters
with an additional component which usually, but not nec-
essarily,
[3] contains an N-terminal cysteine. Synthetic
chemists have optimized efficient routes to peptide thio-
esters using tert-butyloxycarbonyl (Boc)-based methods
of solid phase peptide synthesis (SPPS) and, until more
recently, 9-fluorenylmethoxycarbonyl (Fmoc)-based
methods lagged behind.
[4] This is because thioesters them-
selves are not generally stable to the basic reaction condi-
tions commonly employed for Fmoc removal and so a
less direct path to thioesters is often required. Despite
this obstacle, researchers have sought to develop efficient
methods for thioester synthesis using Fmoc-based chemis-
try. The milder reaction conditions employed are general-
ly considered more compatible with a variety of post-
translational modifications and the additional, and some-
times chemically fragile, functionality embedded within
various molecular probes.
[4b]
Using Fmoc-based SPPS, the thioester is usually isolat-
ed following chain assembly and activation of safety-
catch resins,
[5] formed after release of the otherwise fully
protected peptides,
[6] or formed from N-acyl urea termi-
nated peptides
[7] (Scheme 1). Each method appears to
have its own advantages and disadvantages with respect
to chemical yield, ease of monitoring, and user friendli-
ness, but those described above currently appear the most
reliable for the “routine” formation of long (>25 amino
acid residues) peptide thioesters.
1.1. N!S Acyl Transfer
Recently, a number of methods that explore thioester for-
mation via O!S
[8] or N!S
[9] acyl shift have been report-
ed. Methods that involve N!S acyl shift seem particular-
ly attractive since the nature of the acyl transfer-facilitat-
ing “device” can be simplified to cysteine and cysteine
analogues or derivatives (Scheme 2). Furthermore, in
some cases (Scheme 2a, 2c, and 2d) a thioester precursor
can be used directly in ligation experiments, producing
the thioester only transiently as with N-acyl urea termi-
nated peptides.
In most cases N!S acyl shift precursors contain a b-
amino thiol motif. Since the equilibrium (depicted in
Scheme 2) between the amide form of the peptide and
the less stable thioester form (S-peptide) is expected to
reside far to the left, this basic motif is “activated” by a
number of attached groups. In each case the added group
is believed to destabilize the scissile amide bond, making
it more prone to thiolysis, and this is achieved in a
number of ways. Generally:
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Review* The scissile amide bond is N-alkylated (i.e., R=Me
or Et). This influences the position of the N!S acyl
shift equilibrium because the released secondary
amine is more basic. Furthermore, the released secon-
dary amine is less nucleophilic and so S-peptide for-
mation is favored.
* The R-group can also allow additional delocalization
of the amide nitrogen lone pair into an adjacent p-
system, removing electron density from the amide
linkage, resulting in a weaker amide bond.
* The R
1-group has additional functionality that can in-
tercept or transform the amino group that is released
upon S-peptide formation, rendering the reaction irre-
versible.
Several of the developed acyl transfer facilitating devi-
ces include more than one of these features.
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Scheme 1. Some established and emerging Fmoc-based routes to thioesters. Pg=protecting group.
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based SPPS of glycopeptide thioesters, we opted to first
examine the cysteinylprolylester (CPE) method, reported
by Kawakami and Aimoto.
[10] We felt that this method
was particularly attractive because the thioester was
formed post-SPPS, allowing the precursors to be isolated
in high yield and easily characterized. Additionally, since
there was no requirement for specialized reagents or link-
ers, all aspects of the thioester production could be easily
monitored.
We first prepared a short erythropoietin (EPO)-derived
model peptide that was adorned with C-terminal CPE se-
quence (1, Scheme 3).
[12] Upon exposure to typical reac-
tion conditions (N-cysteinyl peptide, 2% w/v MESNa,
pH 7) we were disappointed to find that little reaction
had occurred. Based on previous experience
[13] and addi-
tional reports,
[14] we predicted that the internal cysteine
residue might, in some way, be influencing the process.
When the peptide was resynthesized with the internal cys-
teine residue Acm protected, we found that the reaction
was capable of proceeding as originally proposed, to form
the Ala thioester. In order to “rescue” our non-Acm-pro-
tected peptide we decided to forcibly form the thioester
by heating 1 to 608C in 30% v/v 3-mercaptopropionic
acid (MPA), as previously reported by Hojo
[15] for mer-
captomethyl prolyl esters. However, when the sample was
heated we found that an alternative major product, 2,
emerged which corresponded to the Gly–MPA thioester,
where the peptide had undergone thiolysis at the internal
cysteine site. This result was initially surprising since we
were unaware of any solely chemical method reported to
bring about selective peptide or protein backbone cleav-
age with concomitant thioester formation.
The fact that thiolysis appeared to have taken place se-
lectively across the Gly–Cys junction (no smaller frag-
ments could be observed) suggested that participation
from the neighboring cysteine thiol, in a retro-NCL type
process, was in operation (Scheme 4). Presumably any
peptide or protein sample that contains cysteine could be
a substrate, and indeed fully reduced erythropoietin
Scheme 2. Schematic thioester formation through N!S acyl shift, and some new routes to peptide thioesters using a) the cysteinyl pro-
line ester (CPE) method;
[10] b) N-alkyl cysteine;
[9h,i] c) N-sulfanylethylanilides (SEAlide);
[9f,11] d) bis(2-sulfanylethyl)amide peptides (BSEA);
[9c–e]
e) N-methyl enamides, R
3=linker.
[9g] Species depicted in square brackets are not isolated.
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(Cys7, Cys 29, Cys33, and Cys 161), was shown to under-
go cleavage to afford thioesters. Surprisingly, only two
thioesters could be observed, corresponding to residues
[Ala1–Gly28]–COSCH2CH2CO2H, and [Ala1–His32]–
COSCH2CH2CO2H. There was no evidence for cleavage
at the Ile6–Cys7 junction or the Ala160–Cys161 junction,
and this led us to predict that some selectivity might be
achievable in thioester formation across Xaa–Cys junc-
tions. When 66 KDa bovine serum albumin (BSA), con-
taining over 30 cysteine residues, was subjected to similar
MPA treatment, this protein underwent significant and
complex fragmentation in only 1 h.
These observations led us to the realization that pep-
tides simply equipped with a C-terminal cysteine should
be substrates for thioester formation. The fact that the re-
action occurs at all is presumably because the N!S acyl
shift is facilitated by enhanced protonation of the liberat-
ed amino group below pH 7.
[16] Further model reactions
confirmed that thioester formation could be selective,
particularly across Gly–Cys, His–Cys, and Cys–Cys junc-
tions, and that in these cases the products do not appear
to undergo epimerization of the C-terminal residue
(Table 1).
In substrates where the Xaa of an Xaa–Cys motif was a
b-branched amino acid, there was no appreciable thioest-
er formation. It is noteworthy that alternative Xaa–Cys
motifs such as Ala–Cys, Ser–Cys, and Phe–Cys all ap-
peared capable of forming thioesters under more forcing
conditions, though the potential for epimerization of the
terminal amino acid was not explored in detail. In one ex-
ample, epimerization of the Ala residue appeared to have
occurred to a significant extent (>10%). The presumed
epimeric product was confirmed by synthesis of the d-
Ala-terminated peptide and subjecting it to identical re-
action conditions. The retention time of the thioester de-
Scheme 3. Exposure to CPE peptide 1 to 30% v/v 3-mercaptopropionic acid at 608C for 48 h allowed the peptide thioester 2 to be isolat-
ed in 86% yield.
Scheme 4. Thioester synthesis through N!S acyl transfer.
Table 1. Peptides designed to test for selectivity in MPA-mediated fragmentation.
[12]
Peptide sequence X
8C cleavage X
12C cleavage X
12C:X
8C Isolated 11 mer
yield% calc. m/z obs. m/z calc. m/z obs. m/z
H–AENITTGCAEHC–NH2 793.3 793.5 1233.5 1233.6  1:1 28
H–AENITTGC(Acm)AEHC–NH2 793.3 n/o 1304.5 1304.6 >9:1 39
H–AENITTICAEHC–NH2 849.4 n/o 1289.5 1289.7 >9:1 60
H–AENITTICAEGC–NH2 849.4 n/o 1209.5 1209.7 >9:1 n.d.
H–AENITTGCAEGC–NH2 793.3 793.5 1153.4 1153.6  1:1 26
H–AENITTGCAECC–NH2 793.3 793.5 1199.4 1199.6  1:1 28
H–AENITTGCAEIC–NH2 793.3 793.5 1209.5 n/o 1:9 n.d.
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that of the epimeric product observed when using l-Ala.
The d-Ala-derived thioester had also epimerized to a sig-
nificant extent. No similar phenomenon was observed
when using peptides terminating in His–Cys, or Cys–
Cys.
[17]
What also became apparent from these studies was that
some species could not be easily observed by HPLC
when using MPA as the reagent to effect thioester forma-
tion. MPA has a tendency to precipitate from the reaction
mixture upon extended reaction time, and additional
MPA-derived peaks are observed in the HPLC trace as
the reaction progresses. Furthermore, the acidity of MPA
appeared incompatible with Asp residues, as also report-
ed by Hojo,
[15] and so it became clear that new reagents
and reaction conditions would need to be investigated.
2. N!S Acyl-Transfer in Native Peptide
Sequences
2.1. Some Peptide Features That Affect N!S Acyl-Transfer in
Native Peptide Sequences
So far, formation of thioesters via N!S acyl transfer at
Cys-terminated peptides has been shown to proceed
more efficiently when a peptide possesses a His, Gly, or
Cys residue adjacent to the C-terminal Cys.
[12] It is proba-
bly not a coincidence that synthetic peptide thioesters
adorned with these residues at the C-terminus are also
known to react fastest in NCL reactions.
[18] When Xaa–
Cys motifs occur within a peptide sequence, thioester for-
mation can potentially occur more widely, but often with
reduced efficiency. Consequently, while Ala–Cys-termi-
nated peptides can undergo slow thioester formation
under normal conditions (with accompanying epimeriza-
tion), this reaction appears extremely inefficient when the
Ala–Cys motif is situated internally.
An obvious limitation is that when additional especially
labile sites exist within a peptide, these Cys residues must
be protected to prevent unwanted cleavage, or the adja-
cent residue (e.g., Gly) must be substituted (e.g., with
Ala). Although we have observed faster thioester-forming
rates when the scissile site is at the C-terminus of a pep-
tide, rather than situated internally, and prepared as a C-
terminal carboxylic acid rather than a carboxamide,
[17]
this difference in rate is not sufficient to ensure that reac-
tion occurs selectively at the C-terminus. As a conse-
quence, it is a priority to discover new reagents, additives,
reaction conditions, or C-terminal motifs, such that the
process can be improved, although it would be ideal if
the optimal Xaa–Cys motif could be genetically encoded
such that biologically derived proteins could be pro-
cessed.
Asp–Cys sequences were poorly tolerated when heated
to 608C in MPA, and substrate peptides can undergo
complete hydrolysis at the Asp residue over prolonged
reaction times.
[19] This undesirable reaction can be com-
pletely abolished if the conservative substitution from
Asp to Glu is made, although this is not practical for
large proteins. Forming thioesters in Asp-containing pep-
tides at pH 5.8 is currently a compromise solution since
performing the reaction at this pH reduces hydrolysis at
Asp.
A further current limitation is that long peptides are
often particularly prone to precipitation or aggregation
upon periods of prolonged heating, so for the reaction to
be widely applicable to recombinant samples, it is essen-
tial that reaction conditions are developed that allow
thioester formation to proceed at lower temperatures.
The reaction can be conducted in 6m guanidine·HCl, but
while the samples may remain in solution throughout the
experiment, thioester formation can remain inefficient.
While there are clearly still significant obstacles to
overcome, several short (10–15 residues) peptide thioest-
ers can be routinely prepared, using regular peptide se-
quences as thioester precursors, in good yield. Using thio-
esters derived from this novel approach, we have already
assembled biologically active samples of human b-defen-
sin 3 (hBD3),
[20] and the iron-regulatory peptide hepci-
din.
[21] The simplicity with which the precursors can be
prepared has propelled us forward to investigate satisfac-
tory solutions to the current limitations, since they do not
appear overtly intractable.
2.2. Optimal Conditions and Reagents
In order to initiate optimization studies we needed a
useful handle with which reaction progress under varying
conditions could be compared. The previous work of
Aimoto
[22] and Danishefsky
[8b] suggested that employing a
13C-1 labelled Gly–Cys motif would be useful, owing to
the significant difference in
13C NMR chemical shift of
the carbonyl carbon upon conversion from
13CONHR
(approx. 170 ppm) to
13COSR (approx. 200 ppm). Useful-
ly, hydrolysis (
13CO2H) could also be observed
(Figure 1).
[20]
Interestingly, the
13C NMR spectrum appeared free of
any intermediates, suggesting that N!S acyl transfer is
rate-determining. However, although the S-peptide has
not been isolated, it appeared essentially indistinguishable
from the thioester product by
13C NMR, and it is unclear
to what extent it accumulates during the reaction. A reac-
tion that appears complete by
13C NMR can return signif-
icant quantities of starting material following HPLC, sug-
gesting that the S-peptide exists in solution and reverts to
amide upon purification.
[22] These findings then suggest,
that the transthioesterification, rather than the N!S acyl
shift, can determine the rate of the reaction. Both steps
would be affected by changes in pH, and the precise
mechanistic details of the reaction require a more thor-
ough investigation.
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the product distribution, became a useful way to examine
thioester formation under a varying reaction condi-
tions.
[20] Upon screening a small selection of water-soluble
thiols, sodium 2-mercaptoethanesulfonate (MESNa)
quickly emerged as the better thiol additive. Not only did
it have good solubility in water and was free of the
stench, it also caused less hydrolysis of the thioester prod-
uct than MPA. Moreover, unlike MPA, MESNa elutes
long before the peptides, allowing less complicated HPLC
analysis and product isolation. Furthermore, when thio-
ester formation was attempted on a peptide containing a
Ser–Cys motif using MPA at 608C, no thioester product
was formed. When the same reaction was performed at a
higher temperature, a 1:1 ratio of thioester to starting
material was observed, along with further condensation
of the peptide with MPA to form an ester with the hy-
droxyl of the serine.
[12] It has not yet been reinvestigated,
but such side reactions would not be expected when using
MESNa.
The reason for the increased stability towards hydroly-
sis could originate from the fact that the sulfonate moiety
of MESNa (pKa= 2) would be deprotonated in the pH
range of the reaction (pH 2–6) (Scheme 5), whereas MPA
would be considerably protonated. The more negatively
charged MESNa thioester may stabilize the product
against nucleophilic attack by water.
This explanation, in addition to the known acid- or
base-promoted degradation of acetylated b-hydroxy
thiols,
[23] also accounts for the poor stability of thioesters
derived from b-mercaptoethanol or dithiothreitol.
Interestingly the homologous thioacids 2-mercaptoace-
tic acid (MAA, pKa=3.7), 3-mercaptopropionic acid
(MPA, pKa=4.3), and 4-mercaptobutyric acid (MBA, pKa
~4.7) each displayed very different behavior during thio-
ester formation, despite the similarities in pKa. With
MAA as the thiol additive, only transient thioester forma-
tion was observed, followed by rapid hydrolysis. With
MPA, hydrolysis only appeared slowly (after 24 h), and
when using MBA no hydrolysis was observed. In cases
where hydrolysis occurred, it was observed only after sig-
nificant thioester formation, and so it seemed likely that
the thioester product, and not the amide starting material,
was undergoing hydrolysis. This was supported by the ob-
servation that the starting material appeared completely
stable to heating in AcOH (pKa 4.76). These observations
could be explained by participation of the pendant car-
boxylic acid, with anhydride formation accelerating hy-
drolysis (Scheme 6).
Although hydrolysis of thioesters via anhydride inter-
mediates is uncommon, hydrolysis of the anhydride
formed by attack of a nearby nucleophilic carboxyl group
within an active site of 3-hydroxyisobutyryl-CoA hydro-
lase on its substrate has been observed.
[24a] Consequently,
Figure 1.
13C NMR analysis of a Gly
13C-1 labelled Gly–Cys motif undergoing thioester formation.
[20]
Scheme 5. Dissociation of MPA and MESNa thioesters may account for the observed increase in stability of MESNa thioesters towards hy-
drolysis.
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can also account for its increased stability towards hydrol-
ysis. Despite the favorable features of MBA, it was only
poorly water soluble and displayed a tendency to sponta-
neously form the g-thiolactone under the reaction condi-
tions.
Regardless of the thiol additive employed, the reaction
conditions are generally acidic, and the range at which
thioesters are formed is usually from pH 2 to pH 5.8,
using 10% v/v AcOH or 0.1m Na phosphate buffer to
control the pH respectively. However at or above pH 7,
the peptide thioester is hydrolyzed, and when N!S acyl
transfer was carried out in 1% v/v TFA (pH 1) in the ab-
sence of thiol additives, hydrolysis of the peptide across
the Gly–Cys junction was observed. Although sodium
phosphate buffer has been employed to maintain approxi-
mately pH 5.8, increasing the ionic strength of the buffer
(>0.1m) results in more rapid thioester hydrolysis. In
1.0m Na phosphate, pH 5.8, the thioester is only a minor
component of the reaction mixture and hydrolysis pre-
dominates.
The addition of tris-(2-carboxyethyl)phosphine (TCEP)
to the reaction was found to increase the rate of thioester
formation, such that at 508C the conversion to thioester
was closer to that observed at 608C in the absence of
TCEP.
[20] The beneficial effect of TCEP is tentatively at-
tributed to the prevention of disulfide bond formation by
maintaining a reducing environment. However, since
TCEP is known to cause the desulfurization of peptides,
converting Cys to Ala (usually above pH 7),
[25] and to
cause the cleavage of peptides and proteins (above
pH 7),
[26] its use should be monitored carefully. Further-
more, unless solutions of TCEP·HCl are neutralized
before use they can dramatically lower the pH of the re-
action.
A significant additional improvement is observed in the
rate of thioester formation when a precursor contains a
C-terminal carboxylic acid, rather than a C-terminal car-
boxamide (Figure 2).
The reasons for this effect have not been investigated
in detail. Intramolecular protonation of the scissile amide
nitrogen by the carboxyl group is not unfeasible, although
the reaction is already conducted at acidic pH
(Scheme 7). Such protonation of the hydroxythiazolidine
intermediate by the carboxyl group would result in a zwit-
terionic intermediate. The S-peptide may also exist as a
zwitterion and this might positively influence the amide/
S-peptide equilibrium where pKa 1> pKa 2 (Scheme 7b).
Alternatively, thioester formation could be facilitated by
sequential acyl-transfers involving participation of the
carboxyl group (Scheme 7c),
[24b] although this would sug-
gest that all C-terminal amino acids are inherently sus-
ceptible to hydrolysis and so is extremely unlikely.
2.3. Thioester Formation vs. NCL
In some instances the reaction shows a certain degree of
dependence on the peptide concentration. We were keen
to investigate whether NCL can compete with thioester
formation, essentially ligating the released cysteine back
to the peptide thioester, reforming the starting materi-
al.
[27] Initially we had considered that this would be un-
likely because of the low pH at which thioester formation
occurs and the presence of the vast excess (approximately
0.7m) of MESNa. However, since thioester formation is
often observed not to proceed to completion we could
not disregard this possibility. To examine the competitive
potential of NCL, increasing concentrations of d-cysteine
were added into the thioester forming reaction and the
amount of epimer formed was measured (Scheme 8).
Since d-Cys–OH was added to an l-Cys–NH2 terminated
peptide (6), ligation could be readily observed by both
HPLC and mass spectrometry. The d-Cys “epimer” (8),
formed by NCL, was only observed in significant amounts
when the ratio of d-cysteine added to the original peptide
Scheme 6. Neighboring group participation of the pendant carboxyl group may catalyze thioester hydrolysis.
[24]
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in rates of thioester formation between carboxyl- and car-
boxamide-terminated peptides was not considered, the re-
sults clearly indicated that competing NCL occurs under
the reaction conditions, but only becomes significant
when d-Cys is added in large excess. From these results
we concluded that, although thioester formation is rever-
sible, the limited amount of “free” cysteine available ( 
1 equiv) under normal reaction conditions precludes sig-
nificant interference from NCL.
Nagaike and colleagues reported the rate of N!S acyl
transfer and thioester exchange to be improved by the
use of microwave irradiation.
[15] We have found little ad-
vantage of microwave irradiation over conventional heat-
ing for the formation of peptide thioesters at 608C.
[20] The
reaction can proceed with slower rates at lower tempera-
tures such as 408C, which can reduce the hydrolysis of
Asp-containing peptides sufficiently to allow for the de-
sired thioester formation on these peptides; however the
Figure 2. Reaction profiles of Xaa–Cys-terminated peptides prepared as C-terminal carboxylic acids and as C-terminal carboxamides, upon
exposure to 10% w/v MESNa in 10% v/v AcOH at 608C.
[17] Note: 3ccorresponds to a peptide sequence where the His-Cys motif is relocat-
ed to the N-terminus of the model peptide, and thioester formation is inferred by observation of the N-cysteinyl peptide.
Scheme 7. The presence of the carboxyl group appears to accelerate thioester formation, possibly by a) stabilization of the hydroxythiazo-
lidine intermediate, b) increased pKa of the a-amino group (pKa 1> pKa 2) favoring the S-peptide, c) through neighboring group participa-
tion.
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lower temperatures.
[12]
The search for optimized reagents and conditions is far
from complete. The discovery that small changes in the
structure of thiol additive can dramatically affect the out-
come, as well as the user friendliness, of the reaction is
extremely encouraging. Furthermore, small changes in
precursor structure (i.e., carboxyl vs, carboxamide) can
also significantly affect the rate of thioester formation.
The increased reactivity of carboxyl-terminated substrates
is supported by several HPLC, LC-MS, and
13C NMR la-
belling experiments and suggests that additional “engi-
neering” of the cysteine residue or Xaa–Cys motif should
be possible.
3. “There and Back Again”: Application to Cyclic
Peptide Synthesis
Cyclic peptides are highly prized materials, since the con-
formationally constrained structures can offer enhanced
binding to targets, increased stability to proteolysis, and
enhanced bioavailability.
[28] Although they are of consid-
erable interest as therapeutics, they can be difficult to
prepare by synthetic or biological means.
[29]
A practical consequence of the lower reactivity of
Xaa–Cys–NH2 peptides, compared with Xaa–Cys–OH
peptides, is that the formation of cyclic amide products
from carboxyl-terminated precursors should be favored.
Since the cyclic products result in the formation of an in-
ternal Xaa–Cys motif at the expense of a terminal Xaa–
Cys motif, the preference for cyclic products could be
even more pronounced. Previous studies suggested that
NCL only competes with thioester formation significantly
at high concentrations of added cysteine.
[27] However, we
considered that the high effective Cys concentration in an
intramolecular NCL reaction might render cyclization
feasible. Interestingly, the successful synthesis of cyclic
peptides of biological origin is most often facilitated by
inteins,
[30] which utilize the same peptide rearrangement
process that we would aim to employ.
[31]
Recently we tested this hypothesis with some short, 9–
14 residue antimicrobial peptides derived from mouse b-
defensin, DefB14 The ability of defensins to kill a broad
range of microbes has evolved over millennia, and their
precise mechanism of bacterial cell surface disruption re-
mains a matter for debate. We discovered that a small de-
fensin fragment retains much of the antimicrobial activi-
ty.
[32] and sought to improve its stability through head-to-
tail cyclization.
In one example (9, Scheme 9) we initially examined
thioester formation/cyclization at approximately pH 2
(employing 10% v/v AcOH as solvent) and found that,
although the thioester accumulated, only a small degree
of cyclization took place. Upon increasing the reaction
pH to 5.8 we found that the cyclic peptide 10 emerged
from the reaction as the major product (Scheme 9).
[32b]
We anticipated that raising the pH might reduce the pro-
pensity for N!S acyl transfer, but a compensatory in-
crease in the nucleophilicity of the N-terminal cysteine
could render NCL more effective. An interesting feature
of this reaction is that both retro-NCL and NCL appear
to proceed in the same reaction vessel yet, under the re-
action conditions, are working in concert to produce the
cyclic peptide.
13C NMR analysis of the reaction mixture
does not suggest that the thioester intermediates 11 or 12
accumulate to a significant extent at approximately
pH 5.8.
S-carboxamidomethylated derivatives of the cyclic pep-
tides derived from b-defensins retained much of their
original activity but, disappointingly, their stability in
serum was not significantly enhanced. In contrast we
found that the antimicrobial activity of the mirror image
cyclic peptide (ent-10, P. aeruginosa, MBC=5.6 mm) re-
mained largely unchanged in 10% serum (Figure 3). Con-
sequently, we believe this cyclic mirror image peptide
serves as an excellent lead “scaffold” from which new an-
timicrobial agents could be developed.
Although cyclic peptides ultimately emerge from the
reaction as major products, it is not obvious why this is
the case since the reaction is inherently reversible. It is
unlikely that the relative stabilities of Xaa–Cys–NH2 and
Xaa–Cys–OH alone account for the outcome. Peptides
terminating in an Xaa–Cys–NH2 motif still undergo cycli-
zation albeit less efficiently, suggesting that the internal
nature of the cyclic amide bond within the product is also
important. Since water appears to be the best solvent for
the reaction, it is possible that the more compact and hy-
drophobic nature of the cyclic product also inhibits rever-
sion to linear species by excluding water from the reac-
tion site. Furthermore, the conformational constraints im-
posed by cyclization could present an additional obstacle
for the internal Cys, preventing it from attaining an ap-
propriate geometry for N!S acyl transfer.
Scheme 8. The extent to which NCL competes with thioester formation can be examined by addition of increasing concentrations of d-
Cys during thioester formation.
[27]
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tides, equipped simply with an N-terminal Cys and an ap-
propriate C-terminal Xaa–Cys motif, are able to undergo
head-to-tail cyclization, and that this process is likely ap-
plicable to many cyclic peptides of biological or medicinal
interest.
4.
4.1. Synthesis of Post-Translationally Modified Peptide
Thioesters via N!S Acyl Transfer
Relying on heating peptide samples to 608C at mildly
acidic pH could certainly raise concern that this method
could not be applied to peptides decorated with non-pep-
tide appendages such as carbohydrates. For example, the
acetal linkages present in glycopeptides, linking the car-
bohydrate to the peptide backbone in O-linked glycosyla-
tion, or those present in interglycosidic linkages, are well
known to be susceptible to acid hydrolysis. In a typical
example, benzylidene acetal protected sugars can be
cleaved in heated 80% v/v acetic acid. However, in the
case of non-benzylic acetals, catalytic quantities of miner-
al acids are usually employed to cleave glycosides or ace-
tonides efficiently. Considering that proteins that have
undergone post-translational modification (PTM) are of
increasing interest for their regulatory and targeting roles
in biological systems, it is important that they can be ac-
cessed using N!S acyl transfer.
Most PTM occurs on specific amino acid residue side-
chains, and two of the most predominant forms of PTM
Scheme 9. Head to tail cyclization of sequence H–CRKFFARIRGGRGC–OH via N!S acyl transfer followed by NCL.
[32b]
Figure 3. Serum sensitivity assays of linear (light grey) and the S-
carboxamidomethyl (dark grey) derivative of ent-10 against P. aeru-
ginosa strain PAO1 and S. aureus strain ATCC 25923.
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has been shown to be particularly important in the regu-
lation of signal transduction pathways,
[5c,33] while glycosy-
lation plays a key role in diverse biological processes such
as protein folding, cell–cell recognition and adhesion,
immune defense, and improving the circulatory lifetime
of secreted proteins.
[34] Phosphorylation is commonly O-
linked through Ser, Thr, or Tyr, and complex carbohy-
drates (glycans) are most commonly N-linked through
Asn, or O-linked through Ser and Thr. The site of modifi-
cation is not under direct genetic control and can be pres-
ent at one or more residues.
[35] For example, erythropoie-
tin (EPO), a glycoprotein hormone, contains three N-gly-
cosylation sites (Asn
24,A s n
38, and Asn
83) and a single O-
glycosylation site (Ser
126).
[36] Asparagine residues are gly-
cosylated in response to a required Asn–Xaa–Ser/Thr
motif
[36c] whereas the sites of O-glycosylation and phos-
phorylation are dictated more by sequence context.
[37]
Due to substrate/acceptor competition between the proc-
essing enzymes that make up the structure of the glycans,
heterogeneously glycosylated structures (glycoforms) are
observed.
[38] Despite the development of cell culture strat-
egies that can achieve human-like glycosylation, the pro-
teins are isolated as heterogeneous mixtures with respect
to glycan structure and glycosylation site occupancy.
[39]
Phosphoproteins can often be hyperphosphorylated in
substoichiometric fashion, which greatly complicates anal-
yses. It is essential to have homogenous forms of these
proteins to ensure reliable studies of structure–activity re-
lationships. Consequently, much interest has evolved
around the synthesis of homogeneous glycoproteins and
phosphoproteins.
Because solid phase peptide synthesis is limited to pep-
tides with up to approximately 50 amino acid residues,
[40]
NCL is the tool that has been most successful in accessing
homogeneous glycoproteins
[6b,41] and phosphopro-
teins.
[5c,42] Unlike in traditional bioconjugation strategies
for protein modification,
[43] the native glycopeptide struc-
tures can be maintained using NCL or using the thioester
method developed by Aimoto.
[2a,44] However, phospho-
peptide and glycopeptide thioesters can be more difficult
to prepare due to the increased chemical complexity.
During peptide synthesis, the appropriate PTM is usually
introduced as a suitably protected amino acid building
block, and when this is located in the N-cysteinyl peptide
fragment, synthesis can be extremely straightforward.
Often, the real challenge encountered is the synthesis of
the PTM containing thioester.
A major factor contributing to the challenge of post-
translationally modified peptide thioester synthesis is the
fragile nature of these moieties. They are generally in-
compatible with traditional Boc-based chemistry during
which they are repeatedly exposed to TFA and then
HF.
[45] In an attempt to circumvent this problem, an
Fmoc-based strategy is most frequently employed. Most
PTM-containing thioesters have been prepared using the
acylsulfonamide “safety-catch” linker (Scheme 1). How-
ever, manipulations with this linker, including loading
and cleavage, can be difficult to monitor in the absence
of a double linker strategy,
[5f,46] and “off target” alkylation
can occur.
[42] Regardless of this, the Fmoc strategy is still
generally preferred for glycopeptides and phosphopepti-
des, and the mildly acidic to neutral conditions employed
within N!S acyl transfer methods are highly comple-
mentary to the acyl sulfonamide approach.
4.2. Phosphopeptide Thioester Synthesis
Muir and co-workers previously used the sulfonamide
linker in the semisynthesis of the hyperphosphorylated
transmembrane kinase TbR-1.
[5c,42] The phosphorylated
GS region of the protein H–
TTLKDLIYDM*pTTpSGpSGpSGLPL–SBn (residues
175–195, 13) were synthesized using an optimized proce-
dure in a yield of 4.6% (Scheme 10). In order to be suc-
cessful, the methionine residue was substituted for nor-
leucine to preclude a previously observed side reaction
between methionine and iodoacetonitrile during resin ac-
tivation. The thioester was subsequently ligated to the re-
mainder of the TbR-1 cytoplasmic domain, obtained by
recombinant methods.
Macmillan and co-workers also attempted to use the
safety-catch linker but experienced low yields of ~2% in
the synthesis of a short thioester (H–LETVSpTQELY–
SBn, 14).
[47] Upon use of N!S acyl shift, the thioester 15
(H–LETVSpTQELG–SCH2CH2SO3H), which included a
Y27G substitution to facilitate thioester formation, was
synthesized in an unoptimized overall yield of 13%.
[48]
The phosphopeptide thioester was ligated to a recombi-
nant Chk2 kinase ForkHead Associated (FHA) domain
to produce a stoichiometrically phosphorylated protein
that formed a characteristic phosphate-dependant homo-
dimer.
4.3. Glycopeptide Thioester Synthesis
Using the sulfonamide linker to produce a thioester and
NCL, Shin et al.
[5b] were able to synthesize an 82-residue
antibacterial glycopeptide containing two O-linked
GalNAc residues at Thr
10 and Thr
54. The thioester frag-
ment 16 (diptericin residues 1–24) was isolated in 21%
yield (Scheme 11). A similar approach also allowed Mac-
millan and Bertozzi to prepare homogeneous semisyn-
thetic glycoforms of mouse glycosylation-dependant cell
adhesion molecule 1 (GlyCAM-1) containing O-linked
sugars.
[13]
Later, Unverzagt and co-workers were able to synthe-
size a peptide thioester containing an N-linked biantenna-
ry heptasaccharide to make a fragment of RNase B. The
safety-catch linker was activated with trimethysilyldiazo-
methane and the glycopeptide thioester was cleaved from
the resin with ethyl 3-mercaptopropionate and sodium
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then removed under acidic conditions with TFA and pu-
rification of the thioester yielded 46%.
[5f] However, since
TFA cleavage conditions have been found to be incom-
patible with certain glycosidic linkages (for example, fu-
cosidic linkages in EPO), Danishefsky et al.
[49] explored
the possibility of incorporating a glycan after peptide syn-
thesis via Lansbury aspartylation.
[50] An unsymmetrical
aryl–alkyl disulfide was coupled to a peptide to form 17,
which was subsequently glycosylated with a chitobiose-
derived glycosylamine to give 18. After reduction under
ligation conditions, it was proposed that 18 underwent in-
tramolecular O!S acyl shift to generate thioester 19 in
situ, which was then able to participate in NCL.
Ozawa et al. were able to use an N!S acyl shift to
generate glycopeptide thioesters.
[51] After installation of
N-alkyl cysteine (NAC) on CLEAR amide resin, the rest
of the peptide chain was elongated using standard Fmoc
protocols. The carbohydrate moieties were introduced
using the appropriate glycoaminoacid building block.
After complete assembly, the product 20 was cleaved
from the solid support and dissolved in 5% MPA solu-
tion, facilitating conversion to the thioester 21 in 2 days.
This proceeded without significant decomposition of car-
bohydrate appendages, with an overall yield of 20% (cal-
culated from initial resin loading).
Masania et al. were also able to apply N!S acyl trans-
fer in the context of glycopeptides. Glycosylation-depend-
ant cell adhesion molecule 1 (GlyCAM-1) residues 75–82
H–GSSQLEETSGC–OH (22) were assembled as a
model O-linked glycopeptide incorporating Fmoc–
GalNAc(OAc)3-Thr–OH at position 82.
[48] An analogue
of cell surface glycopeptide CD52 (24) was also prepared,
substituting Asn
3 with azidohomoalanine (Aha). This ena-
bled the attachment of N-acetyl glucosamine through an
unnatural triazole linkage formed through Cu
I-mediated
cycloaddition.
[52] After being cleaved from the solid sup-
port, both glycopeptides were subjected to thioesterifica-
tion conditions (10% w/v MESNa, 0.1m Na phosphate;
pH 5.8, 558C for 72 h) to generate thioesters 23 (10%)
and 25 (18%), respectively.
More recently we investigated N!S acyl shift in the
preparation of N-linked glycopeptides.
[27] EPO residues
22–28 H–AEN(GlcNAc(OAc)3)ITTGC (26) were assem-
bled on NovaSynTGT resin and subjected to thioesterifi-
cation (10% w/v MESNa, 0.5% w/v TCEP, 0.1m Na
Phosphate; pH 5.8, 558C for 48 h) to give thioester 27
with a good overall yield of 21%. Conducting the reac-
tion at pH 5.8 was important, since at lower pH the acetyl
esters were cleaved, giving rise to a complex mixture of
partially deacetylated compounds. It would have been ex-
tremely convenient if quantitative deacetylation had ac-
companied thioester formation, but deacetylation pro-
ceeded slowly (at pH 2) and longer reaction times result-
ed in increased thioester hydrolysis. Although only a
single monosaccharide was introduced, glycopeptide/pro-
tein remodelling strategies can elaborate these simple gly-
copeptides into more complex structures.
[53]
Overall, use of N!S acyl transfer in the formation of
post-translationally modified peptide thioesters has dem-
onstrated versatility in application to phosphoproteins,
glycoproteins, and their analogues. We have also shown
the tolerance of a variety of non-peptidic linkages to this
reaction. Moreover the efficiency of this process is re-
flected in good yields without the requirement for special-
ized resins, linkers, and unnatural building blocks.
Scheme 10. Fmoc phosphopeptide thioester synthesis; reagents and conditions i) a) Fmoc SPPS; b) ICH2CN, DIPEA; c) BnSH, DIPEA; d) TFA,
scavengers. ii) a) Fmoc SPPS; b) ICH2CN, DIPEA (twice); c) BnSH, PhSH; d) TFA, scavengers. iii) 10% w/v MESNa, 0.1m Na phosphate pH 5.8,
558C, 72 h.
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N!S acyl transfer is clearly emerging as a useful route to
peptide thioesters, which are important intermediates in
protein synthesis. It is especially interesting that native
peptides have the ability to rearrange into thioesters,
since this suggests that proteins have always had, at least
in theory, an inherent ability to make themselves through
N!S acyl transfer and NCL. The required information
for the production of the key components for NCL,
which can be challenging to produce with modern syn-
thetic methods, is already installed in an Xaa–Cys motif.
The biological relevance or consequence of this process
is yet to be examined in detail. One could take the view
that cysteine is an amino acid whose rogue properties re-
quire that it is “tied up” in disulfide bonds or coordinated
to metals if it cannot be deleted entirely. It would be ex-
pected that hyperthermophiles would evolve to remove
all but the most essential Cys residues. Indeed, hyperther-
Scheme 11. Fmoc-based approaches to glycopeptide thioester synthesis: a) using the sulfonamide safety-catch linker;
[5b] b) phenolic
ester;
[16a] c) N-alkyl cysteine, R=b-d-Gal, R
1=CH2CH2CO2H;
[51] d–f) Cys terminated peptides.
[27,48]
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with mesophiles. An alternative view is that, as life
thrived in a more temperate environment, new opportuni-
ties have emerged for this uniquely reactive amino acid.
Additionally, proteins have been exposed as being in-
herently hydrolytically labile across Xaa–Cys sites in a
manner that was not widely appreciated in the past. This
may find application in proteomics as well as in the thio-
ester syntheses that we have explored thus far.
Major challenges to address in thioester formation
from native peptide sequences are the requirements for
elevated reaction temperatures and acidic pH, especially
when several “device”-driven routes produce thioesters at
ambient temperature and neutral pH. An advantage of
using native sequences is that they can be genetically en-
coded and therefore applied to samples of biological
origin, but several obstacles (described in Section 2.1)
still need to be addressed for this to become generally ap-
plicable. Further engineering of N!S acyl transfer devi-
ces is likely to continue apace, and both improved pro-
cesses and additives that can influence the acyl transfer
equilibrium will emerge.
Unlike when using inteins in bring about thioester syn-
thesis, most of the processes discussed above cannot cur-
rently be applied in cell culture. But it is not unimagina-
ble that an optimized, caged acyl transfer facilitating
device could be genetically encoded such that C-terminal
protein thioesters or thioester precursors could be pro-
duced in the absence of inteins.
[54]
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